ANNUAL COSTS OF BEST SUPPORTIVE CARE FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) IN GERMANY

被引：0
作者：
Mathes, J. [1 ]
Kern, B. [1 ]
Kotowa, W. [1 ]
机构：
[1] IGES Inst GmbH, Nurnberg, Germany
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.184
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN101
引用
收藏
页码：A430 / A430
页数：1
相关论文
共 50 条
  • [41] Treatment of advanced non-small-cell lung cancer in the elderly: From best supportive care to the combination of platin-based chemotherapy and targeted therapies
    Gridelli, Cesare
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 13 - 15
  • [42] Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices
    Feld, Emily
    Singhi, Eric K.
    Phillips, Sharon
    Huang, Li-Ching
    Shyr, Yu
    Horn, Leora
    CLINICAL LUNG CANCER, 2019, 20 (03) : E291 - E298
  • [43] Prognostic factors for clinical outcome in advanced non-small-cell lung cancer (NSCLC)
    Otero-Romero, A.
    Navarro-Domenech, I.
    Roman-Jobacho, A.
    Perez-Rozos, A.
    Fernandez-Forne, A.
    Correa-Generoso, R.
    Ordonez-Marmolejo, R.
    Garcia-Rios, I.
    Garcia-Anaya, M.
    Gomez-Millan, J.
    Medina-Carmona, J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S751 - S751
  • [44] Total cost per year associated with "Best Supportive Care" of patients with unresectable advanced non-small-cell lung cancer (NSCLC) under "real-world-conditions" in relation to results of international studies
    Feuerbach, M.
    Freigang, F.
    Lipp, R.
    Oncology Research and Treatment, 2015, 38 : 157 - 158
  • [45] PHARMACOGENETIC STUDY IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NSCLC) TREATED WITH PEMETREXED
    Yasue, T.
    Hirashima, T.
    Kobayashi, M.
    Okamoto, N.
    Suzuki, H.
    Hosono, K.
    Morishita, N.
    Matsuura, Y.
    Tamiya, M.
    Shiroyama, T.
    Morita, S.
    Matsumoto, T.
    Morishita, H.
    Kawahara, K.
    Kawase, I.
    ANNALS OF ONCOLOGY, 2012, 23 : 136 - 136
  • [46] A RANDOMIZED TRIAL OF CISPLATIN AND VINDESINE VERSUS SUPPORTIVE CARE ONLY IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    WOODS, RL
    WILLIAMS, CJ
    LEVI, J
    PAGE, J
    BELL, D
    BYRNE, M
    KERESTES, ZL
    BRITISH JOURNAL OF CANCER, 1990, 61 (04) : 608 - 611
  • [47] Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients
    Jafri, Syed Hasan Raza
    Previgliano, Carlos
    Khandelwal, Keerti
    Shi, Runhua
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2015, 9 : 87 - 93
  • [48] Chemotherapy for elderly patients with advanced non-small-cell lung cancer
    Bunn, PA
    Lilenbaum, R
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (05) : 341 - 343
  • [49] Chemotherapy for Advanced Non-Small-Cell Lung Cancer in Elderly Patients
    Nasser, Fabio
    Souza Cruz, Marcelo Rocha
    Riera, Rachel
    JAMA ONCOLOGY, 2016, 2 (12) : 1645 - 1646
  • [50] Circadian function in patients with advanced non-small-cell lung cancer
    R D Levin
    M A Daehler
    J F Grutsch
    J Quiton
    C G Lis
    C Peterson
    D Gupta
    K Watson
    D Layer
    S Huff-Adams
    B Desai
    P Sharma
    M Wallam
    M Delioukina
    P Ball
    M Bryant
    M Ashford
    D Copeland
    M Ohmori
    P A Wood
    W J M Hrushesky
    British Journal of Cancer, 2005, 93 : 1202 - 1208
12345